Biohaven
Manufacturing · Connecticut, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
234 Church St, New Haven, Connecticut, 0...Phone Number
(203) 404-0410Website
www.biohaven.comRevenue
$541.5 MillionStock Symbol
BHVNIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Biohaven
Founded in 2022, Biohaven is a pharmaceutical company developing and commercializing life changing new therapies for people with debilitating diseases.Explore more
Biohaven Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biohaven your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Biohaven is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Biohaven
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Biohaven launches new products
Biohaven, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Biohaven had a recent Job posting/layoffs
Earning: See what the market has to say on Biohaven recently announced quarterly report
Funding: Get notified immidiatlly once Biohaven has new funding data
Check if Biohaven has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Biohaven
Compare insights from companies similar to Biohaven, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Biohaven is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biohaven is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biohaven.
Biohaven Tech Stack
A closer look at the technologies used by Biohaven
See more technologies
Most Recent Scoops
Person-Based
Earnings, Pharmaceuticals, Clinical Operations, Finance
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Person-Based
Person-Based
Intellectual Property, Lawsuits, Legal Affairs
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Biohaven News & Media
Biohaven (BHVN) Cashes In On Its Biggest Epilepsy Bet
On August 26, Biohaven (NYSE:BHVN) and SK Biopharmaceuticals announced a global licensing agreement covering opakalim, Biohaven’s lead epilepsy candidate, in a deal worth up to $795 million plus royalties. SK Biopharmaceuticals picks up exclusive worldwide rights to Biohaven’s Kv7 ion channel platform, while Biohaven walks away with $400 million in near-term cash. The timing lines […]SK Biopharmaceuticals to In-License Epilepsy Drug Candidate 'Opakalim'
Paves the Way to Launch its Second Innovative Drug Directly in the U.S. Announces agreement to in-license near-commercial candidate at a press conference Targets U.S. commercial launch as early as 2029… Upfront and milestone payments related to the Kv7 platform of up to $795M, plus tiered...Biohaven and SK Biopharmaceuticals Enter into Strategic Global Licensing Agreement for Novel Kv7 Ion Channel Platform and Opakalim, Lead Candidate for Epilepsy
SK Biopharmaceuticals to provide upfront and milestone payments related to the Kv7 platform up to $795 million, along with tiered royalties to Biohaven ranging from the mid-teens to low twenties on U.S. net sales of opakalim. Opakalim, the lead candidate from Biohaven's Kv7 platform, is a...Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale University
NEW HAVEN, Conn., Aug. 25, 2026 /PRNewswire/ -- Biohaven Ltd. and/or its wholly owned subsidiaries ("Biohaven") (NYSE: BHVN) and Yale University ("Yale") today announced that the U.S. District Court for the District of Delaware has entered judgment in their favor in the trade secret...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biohaven
Sign Up For FreeTo access detailed company insights
Founded in 2022, Biohaven is a pharmaceutical company developing and commercializing life changing new therapies for people with debilitating diseases.... Read More
